CompanyBiotechnology
Lyell Immunopharma
A clinical-stage cell therapy company that develops T cell reprogramming technologies for patients with solid tumors.
BiotechnologyCell TherapyCancer Treatment
A clinical-stage cell therapy company that develops T cell reprogramming technologies for patients with solid tumors.